- Epinephrine, auto-injectors and anaphylaxis: Challenges of dose, depth and device
- Gemcitabine-oxaliplatin plus rituximab (R-GemOx) as first-line treatment in elderly patients with diffuse large B-cell lymphoma: A single-arm, open-label, phase 2 trial
- [<sup>177</sup>Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): A single-centre, single-arm, phase 2 study
- An early view of real-world patient response to sacubitril/valsartan: a retrospective study of patients with heart failure with reduced ejection fraction
- Evaluation of responsiveness to reduced-dose rituximab in corticotropin/ivig/rituximab combination immunotherapy for opsoclonus-myoclonus syndrome
- Phase II study of single-agent cabozantinib in patients with recurrent clear cell ovarian, primary peritoneal or fallopian tube cancer (NRG-GY001)
- A systematic review and meta-analysis of the effectiveness of acetylcholinesterase inhibitors and memantine in treating the cognitive symptoms of dementia
- Effect of paracetamol/prednisolone vs paracetamol/ibuprofen on post-operative recovery after adult tonsillectomy
- Use of histamine H<sub>2</sub> receptor antagonists and outcomes in patients with heart failure: A nationwide population-based cohort study
- Beta blockers and chronic heart failure patients: Prognostic impact of a dose targeted beta blocker therapy vs heart rate targeted strategy
- Perioperative factors associated with persistent opioid use after extensive abdominal surgery in children and adolescents: A retrospective cohort study
- The effectiveness of trimetazidine treatment in patients with stable angina pectoris of various durations: Results from the CHOICE-2 Study
- Comparing the effects of atorvastatin with sodium valproate (divalproex) on frequency and intensity of frequent migraine headaches: A double-blind randomized controlled study
- Clinical patterns, epidemiology and risk factors of community-acquired urinary tract infection caused by extended-spectrum beta-lactamase producers: A prospective hospital case-control study
- A randomized trial of oral and transdermal rivastigmine for postural instability in Parkinson disease dementia
Feed Sources
